YALE UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1701-10-09
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.yale.edu
Levetiracetam (Keppra) Tolerability in Cocaine Abusing Methadone-maintained Patients.
- First Posted Date
- 2008-01-14
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- Yale University
- Target Recruit Count
- 15
- Registration Number
- NCT00593125
- Locations
- 🇺🇸
VA CT Healthcare System, West Haven, Connecticut, United States
Effect of Medium Chain Fatty Acids on Cognitive Function During Acute Hypoglycemia in Patients With Type 1 Diabetes
Not Applicable
Completed
- Conditions
- Diabetes Mellitus, Type 1
- Interventions
- Dietary Supplement: Medium chain fatty acid (Octanoic and Decanoic acid)Other: Splenda (Placebo Control)
- First Posted Date
- 2008-01-11
- Last Posted Date
- 2015-01-22
- Lead Sponsor
- Yale University
- Target Recruit Count
- 12
- Registration Number
- NCT00592072
- Locations
- 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States
The Impact of Pancreatic Islet Cell Allotransplantation on Cognitive Function in Type 1 Diabetes Mellitus
Completed
- Conditions
- Diabetes Mellitus, Type 1
- First Posted Date
- 2008-01-11
- Last Posted Date
- 2011-10-27
- Lead Sponsor
- Yale University
- Target Recruit Count
- 36
- Registration Number
- NCT00590876
- Locations
- 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States
🇺🇸Yale University School of Medicine, New Haven, Connecticut, United States
Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities
Terminated
- Conditions
- Glioblastoma Multiforme
- Interventions
- Other: dynamic contrast enhanced magnetic resonance imaging
- First Posted Date
- 2008-01-09
- Last Posted Date
- 2014-07-02
- Lead Sponsor
- Yale University
- Target Recruit Count
- 5
- Registration Number
- NCT00589095
- Locations
- 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States
Cannabidiol Treatment of Cognitive Dysfunction in Schizophrenia
Phase 2
Completed
- Conditions
- SchizophreniaSchizoaffective Disorder
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-01-09
- Last Posted Date
- 2017-06-08
- Lead Sponsor
- Yale University
- Target Recruit Count
- 41
- Registration Number
- NCT00588731
- Locations
- 🇺🇸
Yale University, New Haven, Connecticut, United States
The Effects of Estradiol and Progesterone on Arginine Vasopressin Regulation and Serum Sodium Concentration
Not Applicable
Completed
- Conditions
- Exercise Induced Hyponatremia
- Interventions
- Dietary Supplement: Gatorade Endurance FormulaOther: ganirelix acetate
- First Posted Date
- 2008-01-09
- Last Posted Date
- 2020-03-30
- Lead Sponsor
- Yale University
- Target Recruit Count
- 26
- Registration Number
- NCT00589134
- Locations
- 🇺🇸
John B. Pierce Laboratory, New Haven, Connecticut, United States
Ketamine/Placebo Family History Positive Study
- First Posted Date
- 2008-01-09
- Last Posted Date
- 2021-10-06
- Lead Sponsor
- Yale University
- Target Recruit Count
- 99
- Registration Number
- NCT00588952
- Locations
- 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States
C-reactive Protein and Endothelial Dysfunction in Women With Glucose Intolerance
Completed
- Conditions
- Glucose Intolerance
- First Posted Date
- 2008-01-09
- Last Posted Date
- 2020-04-17
- Lead Sponsor
- Yale University
- Target Recruit Count
- 46
- Registration Number
- NCT00589355
- Locations
- 🇺🇸
Yale Center for Clinical Investigation, New Haven, Connecticut, United States
Impact of Diet and/or Exercise-induced Weight Loss on Cardiovascular Risk Factors
Not Applicable
Completed
- Conditions
- Cardiovascular Diseases
- Interventions
- Behavioral: diet and/or exercise
- First Posted Date
- 2008-01-09
- Last Posted Date
- 2020-04-17
- Lead Sponsor
- Yale University
- Target Recruit Count
- 30
- Registration Number
- NCT00588978
- Locations
- 🇺🇸
Yale Center for Clinical Investigation, New Haven, Connecticut, United States
Age Related Changes in Calciotropic Hormones and Their Impact on Male Osteoporosis
Completed
- Conditions
- Low Bone Density
- First Posted Date
- 2008-01-09
- Last Posted Date
- 2023-08-30
- Lead Sponsor
- Yale University
- Target Recruit Count
- 24
- Registration Number
- NCT00588874
- Locations
- 🇺🇸
Yale Center for Clinical Investigation, New Haven, Connecticut, United States
© Copyright 2025. All Rights Reserved by MedPath